The aim of the study was to evaluate the antiproliferative properties of a new dinuclear platinum(II) complex Pt12 (Fig. 1) used together with anti-MUC1 monoclonal antibody in human breast cancer cells and human fibroblasts. Here, MUC1 is linked to breast cancer.